Thanks to you, 2019 was a phenomenal year for prostate cancer research breakthroughs. And with 15,356 contacts to our Specialist Nurses it was also our biggest ever year for our support services too.
The last year saw the announcement of the world’s first precision medicine for prostate cancer and huge progress towards the development of a home urine test. Just some of the things that made 2019 one of the most innovative years in prostate cancer research history.
Ahead of hosting our Carol concert in Liverpool this December, legendary British actor Dean Sullivan, known for playing lovable rogue Jimmy Corkhill in Brookside, speaks about his treatment and diagnosis.
Nurse Amelia Barber, from Guy’s Hospital in London wins the People’s Choice Award winner for her outstanding dedication to supporting men with prostate cancer.
Ahead of tonight's documentary we spoke to our ambassador Bill Turnbull about diagnosis, chemotherapy and the Turnbull/Fry effect.
There are so many myths out there about prostate cancer and lots of misunderstanding about who is at risk, how to be tested and when to have treatment. Our Specialist Nurse Meg lays the facts on the line.
For the third time in four years, researchers have found a new treatment option to combine with hormone therapy and improve life expectancy for men with advanced prostate cancer.
We publish new best practice guidelines on active surveillance, as NICE advise it should be offered to men with low risk localised prostate cancer.
Focal therapy causes fewer side effects when treating localised prostate cancer, so we’re funding a new trial to see if it’s possible to compare it against surgery and radiotherapy.
Over 80 per cent of men living between 18 and 42 months after a diagnosis of prostate cancer struggle with poor sexual function, yet fewer than half of these men are offered any support to cope with it.